Zoetis

ZTS US Health Care Pharmaceuticals
S&P 500
$72.97
+0.15%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Comfortable interest cover: operating profit covers interest about 15.1 times.
  • Return on equity is healthy at 84.9%.
  • Return on capital employed is healthy at 26.2%.
  • Net profit margin is strong at 28.2%.
  • Current assets comfortably cover current liabilities (current ratio 3.03).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Higher leverage: debt-to-equity of 2.87 is above 1.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
4.53

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Piotroski F-ScoreModerate
5 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$30.15B
Current Price$ 72.97
High / Low$ 149.75 / 71.00
Stock P/E11.903752
Book Value$ 7.54
Dividend Yield2.83%
ROCE26.16%
ROE84.91%
Debt to Equity2.87
Current Ratio3.03
P/B Ratio9.308585
EPS$ 6.02
Debt$9.04B
PAT Margin28.23%
Cash PAT$3.16B
ICR15.14
Educational data only. Not a recommendation to buy, sell or hold any security.